Skip to content

Efficacy of Pasteurization of resected tumor bearing bone and immediate reimplantation in surgical treatment of malignant bone tumours

Efficacy of Pasteurization of resected tumor bearing bone and immediate reimplantation in surgical treatment of malignant bone tumours

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/091/000193
Enrollment
15
Registered
2011-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr. Ajay Puri, Professor & Surgeon, Bone & Soft Tissue Dept., Tata Memorial Hospital, Dr. Ernest Borges Marg, Parel, Mumbai 400 012 Contact no.- 91-22-2417 7000 Ext. 4295 E-mail: docpuri@gmail.com
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Preclinical Phase: a)Patients with high-grade sarcoma undergoing amputation surgery b) Patients where histological evaluation of necrosis is not required for management. Clinical Phase: All diaphyseal tumors where resection is possible with a wide margin and reconstruction possible with available implants

Exclusion criteria

Exclusion criteria: Preclinical phase: a)Patient not undergoing amputation or palliative surgery, b) Low grade tumor c) Patients where histological evaluation of necrosis is required for treatment Clinical Phase a) Cases where Resection with wide margin is not possible, b) Tumor extent such that reconstruction is not possible with available implants c) Resections that would involve removal of the articular surface

Design outcomes

Primary

MeasureTime frame
Histological changes in the tumor tissue caused by pasteurization and efficacy of pasteurization technique in killing malignant bone tumour cells.Timepoint: 1 year.

Secondary

MeasureTime frame
The effect of pasteurization on the mechanical and osteoinductive properties of treated bone. This will be done by the clinical study on 10 patients to study the clinical efficacy in terms of time to incorporation and local control.Timepoint: 1 year.

Countries

India

Contacts

Public ContactDr. Ashish Gulia
draashish15@yahoo.co.in91-22-2417 7000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026